VIARTIS

 

 

 PARKINSON'S DISEASE NEWS

 

 

 

 

 

4th April 2012 - News release

NEUPRO APPROVED FOR PARKINSON'S DISEASE

The U.S. Food and Drug Administration (FDA) have approved the use of UCB's drug Neupro (rotigotine transdermal system) in the U.S.A. for the treatment of the signs and symptoms of advanced stage idiopathic Parkinsonís Disease and as a treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).  The FDA has also approved UCBís new formulation of Neupro. Neupro will be available in U.S. retail pharmacies in July 2012. For more information go to the News release.

In April 2008, Neupro was withdrawn from use in the U.S.A. because specific batches of Neupro had deviated from their specification. In June 2009, UCB proposed new refrigerated storage conditions to alleviate crystallization on the patches. UCB made progress in reformulation and remained committed to bringing Neupro to U.S. patients. For more information go to the News release. Neupro is a dopamine agonist patch that provides continuous drug delivery. Rather than being in tablet form, Neupro uses a transdermal patch. For more information go to Neupro. For the most recent clinical trial results of Neupro go to Clinical trial results. For a printable version of this article click hereFor more current news go to Parkinson's Disease News.

 

E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new articles are added to Parkinson's Disease News,  please merely e-mail mail@viartis.net with the message "subscribe".  No form of identity is required.  E-mail addresses are not used for any other purpose.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Parkinson's Disease books and DVDs from Amazon.com 

LOW RESOLUTION VERSION : There is a low resolution version of PARKINSON'S DISEASE NEWS INTENDED FOR THOSE PEOPLE THAT EITHER : use 800x600 resolution on their monitors, or have eyesight difficulties, or slow Internet speeds. GO TO LOW RESOLUTION VERSION

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports

                                    

   

 

 
©2006-2012  Viartis
 
2012-04-04 13:47:37
 
mail@viartis.net